JTC’s 2025 Trading Update: Resilient performance, record wins, and steady execution
JTC has posted a pre-close update that strikes a confident tone. The headline is simple: record new business wins across the Group and trading in line with the Board’s expectations for the year ended 31 December 2025.
Both divisions – Institutional Capital Services (ICS) and Private Capital Services (PCS) – delivered new business win growth of greater than 20%. That is impressive given the “ongoing macro-economic headwinds”, especially in ICS markets. Those headwinds led to longer lead times from winning mandates to revenue kicking in, which limited short-term net organic revenue growth, though the company says organic revenue still “grew strongly”.
Why the Citi Trust and KHT acquisitions matter for JTC
2025 was also a landmark year for two strategic bank carve-outs, which are transactions where a business is separated from a bank and integrated into a new owner.
Citi Trust integration on track for target margins by end 2026
JTC completed the acquisition of Citi’s global fiduciary and trust administration services business (formerly Citi Trust) on 1 July 2025. Management says integration is progressing well and remains on track to deliver within Group margin guidance by the end of 2026. The deal “cements JTC as the world’s leading independent provider of global trust services”, reinforcing PCS as a market leader.
Kleinwort Hambros Trust to be earnings accretive in 2026
The acquisition of Kleinwort Hambros Trust (KHT) completed in Q4 2025 and is expected to be earnings accretive in 2026. In plain English, “earnings accretive” means it should increase JTC’s earnings per share once integrated. KHT is highly complementary to PCS and also brings a small, high-quality Employer Solutions business, which now sits within ICS.
ICS vs PCS: strong demand, slower conversion in ICS
It is notable that both divisions put up >20% growth in new business wins, but the update flags longer lead times in ICS. That is typical when institutional clients extend decision cycles or onboarding stretches out, and it means revenue recognition can lag deal wins. The company still calls net organic revenue growth “strong”, which suggests momentum remains intact even if the cash register rings a little later in ICS.
Permira takeover: price, votes and timetable
On 10 November 2025, JTC agreed a recommended cash offer from Papilio Bidco Limited (an entity controlled by Permira) at £13.40 per share, implying an enterprise value of approximately £2.7 billion. Shareholders gave overwhelming support, with 99.97% of votes cast in favour at the Court Meeting and General Meeting on 15 January 2026.
Completion is targeted for the third quarter of 2026, subject to ongoing regulatory approvals. The company remains in an Offer Period, which also explains why there will be no management presentation alongside the upcoming results.
What this means for shareholders right now
- The operational story is positive: record wins, growth across both divisions, and integrations that are reported as on track.
- The strategic story is stronger: Citi Trust and KHT deepen PCS leadership and add scale and capability that should support margins by end 2026.
- The investment story is anchored to the deal: with a cash offer of £13.40 per share on the table and shareholder approval secured, near-term share price movement is likely to be driven by the path to completion and regulatory clearances.
- If the deal completes as planned in Q3 2026, shareholders should receive the cash consideration. If it were delayed or did not complete, the fundamentals outlined here – record wins and integration progress – are the operational backstop, but there is no separate guidance disclosed today.
Key dates and disclosed numbers at a glance
| Offer price per share | £13.40 |
| Implied enterprise value | c. £2.7bn |
| Shareholder vote outcome | 99.97% in favour |
| Expected deal completion | Q3 2026 (subject to regulatory approvals) |
| New business wins | Record year; >20% growth in both ICS and PCS |
| Organic revenue growth | Grew strongly (exact figure not disclosed) |
| Citi Trust acquisition completion | 1 July 2025 |
| Citi Trust integration target | Within Group margin guidance by end 2026 |
| KHT acquisition completion | Final quarter of 2025 |
| KHT financial impact | Earnings accretive in 2026 |
| Full-year results date | Tuesday 7 April 2026 |
| Management briefing on results day | No (Company remains in an Offer Period) |
My take: solid execution, deal-driven near term
- Positives: Record new business wins, broad-based demand across ICS and PCS, two sizeable bank carve-outs integrating well, and a clear margin timeline for Citi Trust. The 99.97% vote in favour of the Permira deal shows overwhelming shareholder support.
- Watch-outs: ICS markets still face macro headwinds leading to longer lead times. Integration always carries execution risk, even if progress is currently on track. The timetable for completion rests on regulatory approvals. Also, detailed financials such as revenue, margins or cash flow are not disclosed in this update and will have to wait for results on 7 April 2026.
Quick jargon buster
- ICS and PCS: JTC’s two divisions – Institutional Capital Services (for institutional clients) and Private Capital Services (for private clients, families and related structures).
- Bank carve-out: Buying a business carved out of a bank, which often brings scale and high-quality clients but requires careful integration.
- Earnings accretive: A deal that increases earnings per share after integration.
- Enterprise value: The total value of a company including debt and cash, not just equity.
- Offer Period: A formal period under takeover rules when communications are restricted and closely regulated.
Bottom line
JTC delivered record new business in 2025 and kept growth balanced across both divisions despite tougher markets. Integrations of Citi Trust and KHT appear to be on track, with margins and earnings benefits guided for 2026. With the £13.40 per share cash offer overwhelmingly approved, the key catalyst now is regulatory clearance and completion in Q3 2026.
